Proteomics International Laboratories Ltd (ASX:PIQ)
Australia · Delayed Price · Currency is AUD 0.1450
0.00 (0.00%)
Jul 31, 2026, 1:12 PM AEST
ASX:PIQ Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 7.67 | 11.04 | 6.64 | 6.03 | 2.11 | 5.6 |
Cash & Short-Term Investments | 7.67 | 11.04 | 6.64 | 6.03 | 2.11 | 5.6 |
Cash Growth | -30.51% | 66.21% | 10.17% | 185.45% | -62.33% | 136.99% |
Accounts Receivable | 0.18 | 0.24 | 0.18 | 0.15 | 0.44 | 0.26 |
Other Receivables | 0.05 | 2.13 | 2.22 | 1.94 | 1.72 | 1.33 |
Receivables | 0.22 | 2.38 | 2.41 | 2.15 | 2.16 | 1.59 |
Prepaid Expenses | 0.1 | 0.09 | 0.1 | 0.12 | 0.08 | 0.13 |
Other Current Assets | 0.01 | 0.02 | 0.02 | 0.03 | 0.01 | 0.01 |
Total Current Assets | 8 | 13.52 | 9.16 | 8.33 | 4.36 | 7.34 |
Property, Plant & Equipment | 3.3 | 1.26 | 1.71 | 1.69 | 0.97 | 1.26 |
Other Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
Other Long-Term Assets | -0 | - | - | 0.06 | 0.06 | - |
Total Assets | 11.3 | 14.78 | 10.88 | 10.08 | 5.4 | 8.6 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 0.47 | - | 0.06 | 0.15 | 0.52 | 0.14 |
Accrued Expenses | 0.63 | 0.33 | 0.24 | 0.12 | - | 0.18 |
Current Portion of Leases | 0.23 | 0.15 | 0.1 | 0.03 | - | 0.07 |
Current Unearned Revenue | 0.9 | 0.17 | 0.25 | 0.37 | 0.36 | 0.27 |
Other Current Liabilities | 0.25 | 0.78 | 0.26 | 0.43 | 0.83 | 0.12 |
Total Current Liabilities | 2.48 | 1.44 | 0.9 | 1.1 | 1.7 | 0.78 |
Long-Term Leases | 0.23 | 0.13 | 0.22 | 0.03 | - | - |
Long-Term Unearned Revenue | 1.32 | 0.21 | 0.38 | 0.58 | 0.13 | 0.1 |
Other Long-Term Liabilities | 0.07 | 0.04 | 0.12 | 0.03 | 0.17 | 0.11 |
Total Liabilities | 4.09 | 1.81 | 1.63 | 1.75 | 2 | 0.99 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 47.61 | 47.64 | 36.81 | 30.18 | 19.34 | 19.1 |
Retained Earnings | -43.81 | -37.79 | -29.67 | -23.63 | -17.63 | -12.66 |
Comprehensive Income & Other | 3.65 | 3.32 | 2.27 | 1.83 | 1.68 | 1.17 |
Total Common Equity | 7.45 | 13.17 | 9.41 | 8.38 | 3.39 | 7.61 |
Minority Interest | -0.24 | -0.2 | -0.16 | -0.06 | - | - |
Shareholders' Equity | 7.21 | 12.97 | 9.25 | 8.32 | 3.39 | 7.61 |
Total Liabilities & Equity | 11.3 | 14.78 | 10.88 | 10.08 | 5.4 | 8.6 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 0.45 | 0.28 | 0.32 | 0.06 | - | 0.07 |
Net Cash (Debt) | 7.22 | 10.76 | 6.32 | 5.96 | 2.11 | 5.54 |
Net Cash Growth | -32.94% | 70.14% | 6.05% | 182.41% | -61.86% | 148.00% |
Net Cash Per Share | 0.05 | 0.08 | 0.05 | 0.05 | 0.02 | 0.05 |
Filing Date Shares Outstanding | 163.77 | 163.52 | 130.89 | 122.33 | 114.89 | 105.26 |
Total Common Shares Outstanding | 163.77 | 163.52 | 130.89 | 120.98 | 105.71 | 105.21 |
Working Capital | 5.52 | 12.08 | 8.26 | 7.22 | 2.66 | 6.56 |
Book Value Per Share | 0.05 | 0.08 | 0.07 | 0.07 | 0.03 | 0.07 |
Tangible Book Value | 7.45 | 13.17 | 9.41 | 8.38 | 3.39 | 7.61 |
Tangible Book Value Per Share | 0.05 | 0.08 | 0.07 | 0.07 | 0.03 | 0.07 |
Machinery | 6.23 | 4.23 | 4.14 | 3.74 | - | - |